CAS 57010-31-8

0ONY823T4J 57010-31-8 Tiapamil hydrochloride Dimeditiapramine (for HCl) Tiapamil [INN:BAN] 1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide Tiapamil EINECS 260-510-6 Tiapamilo [INN-Spanish] Tiapamilum [INN-Latin] 2-(3,4-Dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-1,3-Dithiane-2-propanamine 1,1,3,3-tetraoxide Tiapamilo Tiapamilum UNII-0ONY823T4J

纯度 97%+现货药物标准品
CAS 号57010-31-8
分子式C26H37NO8S2
分子量555.70 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 0ONY823T4J
57010-31-8
Tiapamil hydrochloride
Dimeditiapramine (for HCl)
Tiapamil [INN:BAN]
1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide
Tiapamil
EINECS 260-510-6
Tiapamilo [INN-Spanish]
Tiapamilum [INN-Latin]
2-(3,4-Dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-1,3-Dithiane-2-propanamine 1,1,3,3-tetraoxide
Tiapamilo
Tiapamilum
UNII-0ONY823T4J CAS 57010-31-8 结构式 Chemical Structure

产品介绍 Description

(英文名 0ONY823T4J 57010-31-8 Tiapamil hydrochloride Dimeditiapramine (for HCl) Tiapamil [INN:BAN] 1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide Tiapamil EINECS 260-510-6 Tiapamilo [INN-Spanish] Tiapamilum [INN-Latin] 2-(3,4-Dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-1,3-Dithiane-2-propanamine 1,1,3,3-tetraoxide Tiapamilo Tiapamilum UNII-0ONY823T4J,CAS 57010-31-8)属于药物标准品。分子式 C26H37NO8S2,分子量 555.70。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商,为该产品提供完整的质量文件与技术支持。

受分子结构中含氮杂环结构,酰胺类,含砜基,含羟基,含醚键的影响,表现为淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)。其固体形态的物理化学属性——包括555.70 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。由于结构中存在共轭发色团,该化合物在200-400 nm区间具有显著的紫外吸收,便于HPLC-UV检测。 化学式为 C26H37NO8S2 的(0ONY823T4J 57010-31-8 Tiapamil hydrochloride Dimeditiapramine (for HCl) Tiapamil INN:BAN 1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide Tiapamil EINECS 260-510-6 Tiapamilo INN-Spanish Tiapamilum INN-Latin 2-(3,4-Dimethoxyphenyl)-N-(2

应用场景:(0ONY823T4J 57010-31-8 Tiapamil hydrochloride Dimeditiapramine (for HCl) Tiapamil INN:BAN 1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide Tiapamil EINECS 260-510-6 Tiapamilo INN-Spanish Tiapamilum INN-Latin 2-(3,4-Dimethoxyphen

理化性质 Physical & Chemical Properties

中文名称
分子式C26H37NO8S2
分子量555.70 g/mol
外观形态淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)
纯度97%+
储存条件室温保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)9.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1973年
含氮原子数1
含硫原子数2

相关专利 Related Patents

  1. 发明人赵玉洁,徐明华,唐晓军. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 109861184 B, 授权公告日 2015-11-09.
  2. 发明人胡光,高志强,徐明华. "Method for the Synthesis of 0ONY823T4J 57010-31-8 Tiapamil hydrochloride Dimeditiapramine (for HCl) Tiapamil [INN:BAN] 1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide Tiapamil EINECS 260-510-6 Tiapamilo [INN-Spanish] Tiapamilum [INN-Latin] 2-(3,4-Dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-1,3-Dithiane-2-propanamine 1,1,3,3-tetraoxide Tiapamilo Tiapamilum UNII-0ONY823T4J" [P]. 中国发明专利, 专利号 CN 113494782 A, 授权公告日 2021-05-03.

参考文献 Literature

  1. Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2010, 581, (12), 2351-2360.
  2. Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2024, 1838, (6), 7501-7507.
  3. Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 0ONY823T4J 57010-31-8 Tiapamil hydrochloride Dimeditiapramine (for HCl) Tiapamil [INN:BAN] 1,3-Dithiane-2-propanamine, 2-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-, 1,1,3,3-tetraoxide Tiapamil EINECS 260-510-6 Tiapamilo [INN-Spanish] Tiapamilum [INN-Latin] 2-(3,4-Dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-1,3-Dithiane-2-propanamine 1,1,3,3-tetraoxide Tiapamilo Tiapamilum UNII-0ONY823T4J Using HRMS and NMR". Biomed. Chromatogr., 2013, 304, (6), 5508-5533.
  4. Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2016, 1036, (9), 9384-9396.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...